MARILAO MEDICAL & DIAGNOSTIC CLINIC, INC.

Processed by:

IGULOT RD., BRGY. IGULOT, BOCAUE, BULACAN.

Department of Health License No.: 03-0062-2022-CT-2
Contact No. 09369349510 / 09615324888

Real-Time Reverse Transcription Polymerase Chain Reaction Official Result

176599.2022-10-21 09:12:00MLLOS-0001617.0218367176599

Name: FRANCISCO, JAMES PAOLO H Swab site: LGU MALOLOS

Specimen type: Nasopharyngeal & Oropharyngeal swab

Age: 36
Sex: Male Specimen ID: MLLOS-0001617
Date of birth (YYYY-MM-DD): 1985-12-24 Lab ID: 0218367
Nationality: FILIPINO Date & time of collection:
Passport #: 2022-10-21 09:12:00
Mobile No.: 0 Date & Time release of results:
Address: 100 TAMBUBONG STREET LONGOS CITY OF 2022-10-22 01:15:11
MALOLOS (CAPITAL) BULACAN REGION III

PATHOLOGY TEST PERFORMED RESULT:

Molecular Diagnostic Test SARS-CoV-2 (causative agent of COVID-19) viral RNA
SARS – CoV-2 (causative agent of Covid-19) viral RNA detection by NOT DETECTED
Real-Time Reverse Transcription Polymerase Chain Reaction
INTERPRETATION:
.... NEGATIVE
METHOD: Real-Time Reverse Transcription Polymerase Chain
Reaction (qRT-PCR) was performed to test the presence of SARS-
CoV-2 viral RNA. RNA extraction was performed using an automated
RNA extraction machine to purify viral RNA in the sample. FDA Performed By:
approved SARS-CoV-2 qRT-PCR reagent kits were used to detect
SARS-CoV-2 specific gene targets (RdRp/N/ORF1ab/NSP-3).
Amplification and detection were done using BIORAD CFX96 Real-
Time PCR machine with positive and negative controls included in
each run to confirm validity and accuracy of results.
TEST: Qualitative detection of SARS-CoV-2, the causative agent of
COVID-19, extracted from nasopharyngeal & oropharyngeal swab
samples.
LIMITATION: Pre-analytical variables such as sample collection,
storage, handling and transport may affect the quality of results. The
detection of viral RNA is dependent on the viral load if the sample
was collected early and/or late in the course of infection. PCR results
should not be used as the sole basis of patient treatment
management decision. PCR results should be interpreted by a
physician in conjunction with review of patient’s history and clinical Verified By:
signs and symptoms.
QUALITY ASSURANCE: MMDC is comprised of trained laboratory
personnel in performing molecular diagnostic assays and passed the
external proficiency testing conducted by the Department of Health –
Research Institute for Tropical Medicine.
2022-10-22 01:15:11

FRANCISCO
***Privacy Note: Alinsunod sa Data Privacy act of 2012, ang MMDC ay nangangako na protektahan ang lahat ng personal o sensitibong impormasyon na
nakasulat. Kung may katanungan maaring sumanguni sa MMDC, IGULOT RD., BRGY. IGULOT, BOCAUE, BULACAN.***

Powered by TCPDF (www.tcpdf.org)